Verve Therapeutics
Andrew Dorsey is a formulation research associate at Verve Therapeutics. Prior to joining, Andrew completed two co-ops; first with Lyndra Therapeutics, contributing to formulation work for extended drug release in schizophrenia and Alzheimer’s projects and the other with Takeda Pharmaceutical, in the process chemistry and development group, where he led solubility studies and validation of equipment for the evaluation of alternative step solvents, as well as, assisted with green chemistry evaluation of department projects. He earned a B.S and M.S. in chemical engineering from Northeastern University.
This person is not in the org chart
This person is not in any offices
Verve Therapeutics
59 followers
Verve Therapeutics is a biotechnology company focused on discovering and developing therapies that safely edit the genomes of adults to confer lifelong protection against coronary artery disease, the most common type of heart disease and the leading cause of death worldwide.